BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8227125)

  • 1. Membrane orientation of the human papillomavirus type 16 E5 oncoprotein.
    Krawczyk E; Suprynowicz FA; Sudarshan SR; Schlegel R
    J Virol; 2010 Feb; 84(4):1696-703. PubMed ID: 19955310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serological detection of Bovine papillomavirus's E5 oncoprotein antibodies in horses.
    Hoikhman R; Molinková D; Pillárová D; Linhart P; Kopecká A; Jahn P
    Vet Immunol Immunopathol; 2023 Aug; 262():110633. PubMed ID: 37542957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine papillomavirus E5 and E7 oncoproteins in naturally occurring tumors: are two better than one?
    Corteggio A; Altamura G; Roperto F; Borzacchiello G
    Infect Agent Cancer; 2013 Jan; 8(1):1. PubMed ID: 23302179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II.
    Webster MK; D'Avis PY; Robertson SC; Donoghue DJ
    Mol Cell Biol; 1996 Aug; 16(8):4081-7. PubMed ID: 8754806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.
    Webster MK; Donoghue DJ
    EMBO J; 1996 Feb; 15(3):520-7. PubMed ID: 8599935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular transformation by a transmembrane peptide: structural requirements for the bovine papillomavirus E5 oncoprotein.
    Meyer AN; Xu YF; Webster MK; Smith AE; Donoghue DJ
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4634-8. PubMed ID: 8197111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bovine papillomavirus E5 protein and the PDGF beta receptor: it takes two to tango.
    Talbert-Slagle K; DiMaio D
    Virology; 2009 Feb; 384(2):345-51. PubMed ID: 18990418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal integration at the c-fos promoter.
    Janknecht R; Cahill MA; Nordheim A
    Carcinogenesis; 1995 Mar; 16(3):443-50. PubMed ID: 7697796
    [No Abstract]   [Full Text] [Related]  

  • 9. The v-sis protein retains biological activity as a type II membrane protein when anchored by various signal-anchor domains, including the hydrophobic domain of the bovine papilloma virus E5 oncoprotein.
    Xu YF; Meyer AN; Webster MK; Lee BA; Donoghue DJ
    J Cell Biol; 1993 Nov; 123(3):549-60. PubMed ID: 8227125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The v-sis oncoprotein loses transforming activity when targeted to the early Golgi complex.
    Hart KC; Xu YF; Meyer AN; Lee BA; Donoghue DJ
    J Cell Biol; 1994 Dec; 127(6 Pt 2):1843-57. PubMed ID: 7806564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein.
    Petti LM; Reddy V; Smith SO; DiMaio D
    J Virol; 1997 Oct; 71(10):7318-27. PubMed ID: 9311809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular retention of membrane-anchored v-sis protein abrogates autocrine signal transduction.
    Lee BA; Donoghue DJ
    J Cell Biol; 1992 Sep; 118(5):1057-70. PubMed ID: 1324943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-anchored form of v-sis/PDGF-B induces mitogenesis without detectable PDGF receptor autophosphorylation.
    Lee BA; Donoghue DJ
    J Cell Biol; 1991 Apr; 113(2):361-70. PubMed ID: 1849139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface retention sequence binding protein-1 interacts with the v-sis gene product and platelet-derived growth factor beta-type receptor in simian sarcoma virus-transformed cells.
    Boensch C; Huang SS; Connolly DT; Huang JS
    J Biol Chem; 1999 Apr; 274(15):10582-9. PubMed ID: 10187853
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.